Low molecular weight dextran sulfate: A strong candidate drug to block IBMIR in clinical islet transplantation

American Journal of Transplantation

Volumn 6, Issue 2, 2006, Pages 305-312

  Johansson, H ^a   Goto, M ^a,b   Siegbahn, A ^a   Elgue, G ^a   Korsgren, O ^a   Nilsson, B ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Dextran sulfate; IBMIR

Indexed keywords

DEXTRAN SULFATE; MM 5000;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CELL; BLOOD CLOTTING; COMPLEMENT ACTIVATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; HUMAN TISSUE; IN VIVO STUDY; INFLAMMATION; MALE; METHODOLOGY; MONITORING; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PARTIAL THROMBOPLASTIN TIME; PLASMA; PRIMATE; PRIORITY JOURNAL; THROMBOCYTE;

ANTICOAGULANTS; CADAVER; DEXTRAN SULFATE; HEPARIN; HUMANS; INFLAMMATION; INTRAOPERATIVE COMPLICATIONS; ISLETS OF LANGERHANS TRANSPLANTATION; MOLECULAR WEIGHT; PARTIAL THROMBOPLASTIN TIME; TISSUE DONORS;

EID: 33644904863     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2005.01186.x     Document Type: Article

References (36)

1. Shapiro AM Lakey JR Ryan EA et al Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen N Engl J Med 2000 343 230 238
2. Davalli AM Scaglia L Zangen DH Hollister J Bonner-Weir S Weir GC Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function Diabetes 1996 45 1161 1167
3. Ryan EA Lakey JR Rajotte RV et al Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol Diabetes 2001 50 710 719
4. Bennet W Sundberg B Groth CG et al Incompatibility between human blood and isolated islets of Langerhans: A finding with implications for clinical intraportal islet transplantation¿ Diabetes 1999 48 1907 1914
5. Johansson H Lukinius A Berne C et al Tissue factor released by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation Diabetes 2005 4 1755 1762
6. Moberg L Johansson H Lukinius A et al Production of tissue factor by pancreatic islet cells triggers thrombotic reactions detrimental in clinical islet transplantation Lancet 2002 360 2039 2045
7. International islet transplant registry report Giessen University of Giessen
8. Hedner U Erhardtsen E Future possibilities in the regulation of the extrinsic pathway: rFVIIa and TFPI Ann Med 2000 32 Suppl 1 68 72
9. Wuillemin WA te Velthuis H Lubbers YT de Ruig CP Eldering E Hack CE Potentiation of C1 inhibitor by glycosaminoglycans: Dextran sulfate species are effective inhibitors of in vitro complement activation in plasma J Immunol 1997 159 1953 1960
10. Fiorante P Banz Y Mohacsi PJ et al Low molecular weight dextran sulfate prevents complement activation and delays hyperacute rejection in pig-to-human xenotransplantation models Xenotransplantation 2001 8 24 35
11. Goto M Johansson H Maeda A Elgue G Korsgren O Nilsson B Low molecular weight dextran sulfate prevents the instant blood-mediated inflammatory reaction induced by adult porcine islets Transplantation 2004 77 741 747
12. Matsumiya A Yamaguchi M Nakano H Takeda M Kumada K Dextran sulfate inhibits E-selectin-mediated neutrophil adhesion to endotoxin-activated vascular endothelial cells Life Sci 1999 64 PL9 PL17
13. Zioncheck TF Richardson L Liu J et al Sulfated oligosaccharides promote hepatocyte growth factor association and govern its mitogenic activity J Biol Chem 1995 270 16871 16878
14. Roos F Ryan AM Chamow SM Bennett GL Schwall RH Induction of liver growth in normal mice by infusion of hepatocyte growth factor/scatter factor Am J Physiol 1995 268 G380 G386
15. Nakano M Yasunami Y Maki T et al Hepatocyte growth factor is essential for amelioration of hyperglycemia in streptozotocin-induced diabetic mice receiving a marginal mass of intrahepatic islet grafts Transplantation 2000 69 214 221
16. Goto M Eich T Felldin M et al Refinement of the automated method for human islet isolation and presentation of a closed system for in vitro islet culture Transplantation 2004 78 9 1367 1375
17. Brandhorst H Brandhorst D Brendel MD Hering BJ Bretzel RG Assessment of intracellular insulin content during all steps of human islet isolation procedure Cell Transplant 1998 7 489 495
18. Ricordi C Lacy PE Finke EH Olack BJ Scharp DW Automated method for isolation of human pancreatic islets Diabetes 1988 37 413 420
19. Larsson R Elgue G Larsson A Ekdahl KN Nilsson UR Nilsson B Inhibition of complement activation by soluble recombinant CR1 under conditions resembling those in a cardiopulmonary circuit: Reduced up-regulation of CD11b and complete abrogation of binding of PMNs to the biomaterial surface Immunopharmacology 1997 38 119 127
20. Gong J Larsson R Ekdahl KN Mollnes TE Nilsson U Nilsson B Tubing loops as a model for cardiopulmonary bypass circuits: Both the biomaterial and the blood-gas phase interfaces induce complement activation in an in vitro model J Clin Immunol 1996 16 222 229
21. Sanchez J Elgue G Riesenfeld J Olsson P Studies of adsorption, activation, and inhibition of factor XII on immobilized heparin Thromb Res 1998 89 41 50
22. Nilsson Ekdahl K Nilsson B Pekna M Nilsson UR Generation of iC3 at the interface between blood and gas Scand J Immunol 1992 35 85 91
23. Lorentsen KJ Hendrix CW Collins JM et al Dextran sulfate is poorly absorbed after oral administration Ann Intern Med 1989 111 561 566
24. Jakab F Rath Z Schmal F Nagy P Faller J A new method to measure portal venous and hepatic arterial blood flow in patients intraoperatively HPB Surg 1996 9 239 243
25. Thomas H Maillet F Letourneur D Jozefonvicz J Fischer E Kazatchkine MD Sulfonated dextran inhibits complement activation and complement-dependent cytotoxicity in an in vitro model of hyperacute xenograft rejection Mol Immunol 1996 33 643 648
26. Ozmen L Ekdahl KN Elgue G Larsson R Korsgren O Nilsson B Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: Possible application of the thrombin inhibitor melagatran in clinical islet transplantation Diabetes 2002 51 1779 1784
27. Hartmann NR Johns DG Mitsuya H Pharmacokinetic analysis of dextran sulfate in rats as pertains to its clinical usefulness for therapy of HIV infection AIDS Res Hum Retroviruses 1990 6 805 812
28. Hisazumi J Kobayashi N Nishikawa M Takakura Y Significant role of liver sinusoidal endothelial cells in hepatic uptake and degradation of naked plasmid DNA after intravenous injection Pharm Res 2004 21 1223 1228
29. Thompson GR LDL apheresis Atherosclerosis 2003 167 1 13
30. Hering BJ Kandaswamy R Harmon JV et al Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody Am J Transplant 2004 4 390 401
31. Flexner C Barditch-Crovo PA Kornhauser DM et al Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection Antimicrob Agents Chemother 1991 35 2544 2550
32. Fujishima M Omae T Tanaka K Iino K Matsuo O Mihara H Controlled trial of combined urokinase and dextran sulfate therapy in patients with acute cerebral infarction Angiology 1986 37 487 498
33. Hiebert LM Wice SM Jaques LB Williams KE Conly JM Orally administered dextran sulfate is absorbed in HIV-positive individuals J Lab Clin Med 1999 133 161 170
34. Hiebert LM Liu JM Dextran sulphates protect porcine arterial endothelial cells from free radical injury Hum Exp Toxicol 1994 13 233 239
35. Lasne D Fiemeyer A Chatellier G Chammas C Baron JF Aiach M A study of platelet functions with a new analyzer using high shear stress (PFA 100) in patients undergoing coronary artery bypass graft Thromb Haemost 2000 84 794 799
36. Zeerleder S Mauron T Lammle B Wuillemin WA Effect of Low-molecular weight dextran sulfate on coagulation and platelet function tests Thromb Res 2002 105 5 441 446